hydroxyurea has been researched along with Sarcoma 180 in 9 studies
Sarcoma 180: An experimental sarcoma of mice.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5, or 2 microM vincristine for 4 hr were studied in Sarcoma 180 cells at various times after synchronization with 5 mM hydroxyurea for 1 hr." | 7.66 | Schedule dependence of vincristine lethality in Sarcoma 180 cells following partial synchronization with hydroxyurea. ( Conger, BM; Mujagic, H; Occhipinti, SJ; Schuette, WH; Shackney, SE; Smith, CA, 1983) |
| "The lethal and sublethal effects of hydroxyurea were studied in Sarcoma 180 in vitro in relation to drug concentration and drug exposure duration using cloning methods, radioautography, and flow microfluorometry." | 7.65 | Lethal and sublethal effects of hydroxyurea in relation to drug concentration and duration of drug exposure in sarcoma 180 in vitro. ( Ford, SS; Shackney, SE, 1977) |
| "Influence of hydroxyurea (HU) on the antitumor effect of irinotecan hydrochloride (CPT-11) was investigated in ICR male mice transplanted with sarcoma 180 cells (S-180)." | 3.72 | Cell kinetics-dependent antitumor effect of irinotecan hydrochloride induced by the synchronizing effect of hydroxyurea: cell kinetics and dosing time. ( Akagi, T; Higuchi, S; Inoue, K; Ishizaki, T; Kage, Y; Makinosumi, T; Ohdo, S; Taguchi, Y; Ushinohama, K; Yamauchi, A; Yukawa, E, 2003) |
| "The lethal effects of combinations of adriamycin (ADR) and either hydroxyurea (HU) or 1-beta-d-arabinofuranosylcytosine (ara-C) were studied in relation to drug-scheduling interval in Sarcoma 180 cells grown in vitro." | 3.66 | Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin. ( Cunningham, RE; Occhipinti, SJ; Ritch, PS; Shackney, SE, 1981) |
| "The lethal and sublethal effects of hydroxyurea were studied in Sarcoma 180 in vitro in relation to drug concentration and drug exposure duration using cloning methods, radioautography, and flow microfluorometry." | 3.65 | Lethal and sublethal effects of hydroxyurea in relation to drug concentration and duration of drug exposure in sarcoma 180 in vitro. ( Ford, SS; Shackney, SE, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, T | 1 |
| Ushinohama, K | 1 |
| Kage, Y | 1 |
| Ishizaki, T | 1 |
| Makinosumi, T | 1 |
| Yamauchi, A | 1 |
| Taguchi, Y | 1 |
| Inoue, K | 1 |
| Yukawa, E | 1 |
| Higuchi, S | 1 |
| Ohdo, S | 1 |
| Mujagic, H | 1 |
| Conger, BM | 1 |
| Smith, CA | 1 |
| Occhipinti, SJ | 3 |
| Schuette, WH | 1 |
| Shackney, SE | 4 |
| Ford, SS | 2 |
| Ritch, PS | 2 |
| Riccardi, R | 1 |
| Erickson, BW | 1 |
| Cunningham, RE | 1 |
| Tomita, K | 2 |
| Plager, JE | 1 |
| Satyamoorthy, K | 1 |
| Chitnis, MP | 1 |
| Pradhan, SG | 1 |
| Sugiura, K | 1 |
9 other studies available for hydroxyurea and Sarcoma 180
| Article | Year |
|---|---|
Cell kinetics-dependent antitumor effect of irinotecan hydrochloride induced by the synchronizing effect of hydroxyurea: cell kinetics and dosing time.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Body Weight; Bone Marrow Cells; C | 2003 |
Schedule dependence of vincristine lethality in Sarcoma 180 cells following partial synchronization with hydroxyurea.
Topics: Animals; Cell Division; Cell Survival; DNA Replication; Flow Cytometry; Hydroxyurea; Sarcoma 180; Ti | 1983 |
Schedule optimization of hydroxyurea and 1-beta-D-arabinofuranosylcytosine in sarcoma 180 in vitro.
Topics: Animals; Cell Survival; Clone Cells; Cytarabine; DNA Replication; Dose-Response Relationship, Drug; | 1982 |
Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
Topics: Animals; Cell Line; Cell Survival; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug A | 1981 |
In vivo cell cycle synchronization of the murine sarcoma 180 tumor following alternating periods of hydroxyurea blockade and release.
Topics: Animals; Cell Cycle; Hydroxyurea; Interphase; Kinetics; Male; Mice; Mitosis; Sarcoma 180 | 1979 |
Cell cycle synchronization of the mouse S-180 tumor following alternating period of hydroxyurea-blockade and release.
Topics: Animals; Cell Cycle; DNA, Neoplasm; Hydroxyurea; Interphase; Male; Mice; Mitotic Index; Sarcoma 180 | 1979 |
Lethal and sublethal effects of hydroxyurea in relation to drug concentration and duration of drug exposure in sarcoma 180 in vitro.
Topics: Animals; Autoradiography; Cell Division; Cell Survival; Clone Cells; DNA, Neoplasm; Drug Administrat | 1977 |
Potentiation of hydroxyurea cytotoxicity by iron-chelating agent in murine tumor models in vitro.
Topics: 2,2'-Dipyridyl; Animals; Carcinoma, Ehrlich Tumor; Cell Line; DNA, Neoplasm; Drug Synergism; Hydroxy | 1986 |
Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and two related compounds on a spectrum of tumors.
Topics: Adenocarcinoma; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Krebs 2; Fibrosarcoma; Glioma; Hydroxy | 1967 |